Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Gains from Investment Securities (2021 - 2025)

Zymeworks' Gains from Investment Securities history spans 5 years, with the latest figure at $387000.0 for Q1 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $387000.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $387000.0, a 78.37% decrease, with the full-year FY2024 number at $3.2 million, up 1826.67% from a year prior.
  • Gains from Investment Securities hit $387000.0 in Q1 2025 for Zymeworks, down from $3.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ZYME hit a ceiling of $24.6 million in Q4 2021 and a floor of -$1.2 million in Q2 2024.
  • Historically, Gains from Investment Securities has averaged $3.1 million across 5 years, with a median of $197000.0 in 2022.
  • The widest YoY moves for Gains from Investment Securities: up 6340.0% in 2023, down 677.78% in 2023.
  • Tracing ZYME's Gains from Investment Securities over 5 years: stood at $24.6 million in 2021, then crashed by 59.4% to $10.0 million in 2022, then tumbled by 101.66% to -$166000.0 in 2023, then skyrocketed by 1887.35% to $3.0 million in 2024, then tumbled by 86.96% to $387000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ZYME at $387000.0 in Q1 2025, $3.0 million in Q4 2024, and -$1.2 million in Q2 2024.